Submandibular gland acinar cells express multiple α1- adrenoceptor subtypes

Charles Bockman, Michael R. Bruchas, Wanyun Zeng, Kelly A. O'Connell, Peter W. Abel, Margaret A. Scofield, Frank J. Dowd

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We evaluated an acinar cell line (SMG-C10) cloned from rat submandibular glands as a possible model for α1-adrenoceptor regulation of submandibular function. α1-Adrenoceptors are subdivided into three subtypes called α1A, α1B, and α1D, which can be distinguished from one another by their differential affinity values for subtype-selective α1- adrenoceptor antagonists. Thus, α1-adrenoceptor subtypes in SMG-C10 cells were characterized with reverse transcription-polymerase chain reaction (RT-PCR) and [3H]prazosin binding in side-by-side experiments with native submandibular glands. RT-PCR identified mRNAs for α1A-, α1B-, and α1D- adrenoceptors in SMG-C10 cells and submandibular glands. The inhibition of [3H]prazosin binding by 5-methylurapidil (α1A- selective) was biphasic and fit best to a two-site binding model with 40 ± 8% high (KiH)- and 60 ± 10% low (K iL)-affinity binding sites in SMG-C10 cells, and 76% high- and 24% low-affinity binding sites in submandibular glands. Respective KiH and KiL values for 5-methylurapidil were 1.9 ± 0.4 and 100 ± 30 nM in SMG-C10 cells and 3.2 ± 0.8 and 170 ± 20 nM in submandibular glands. BMY-7378 [8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 8-azaspiro[4.5]decane-7,9-dione dihydrochloride (α1D-selective) ] bound with low affinity in SMG-C10 cells and submandibular glands with K i values of 81 ± 20 and 110 ± 20 nM, respectively. Chloroethylclondine, an irreversible alkylating agent selective for α1B adrenoceptors, reduced the density of [3H] prazosin binding sites by 42 and 26% in SMG-C10 and submandibular membranes, respectively. Thus, SMG-C10 cells and submandibular glands are similar in expressing receptor protein for α1A- and α1B- adrenoceptor subtypes, establishing SMG-C10 cells as a potential model for α1-adrenoceptor-mediated secretion.

Original languageEnglish
Pages (from-to)364-372
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume311
Issue number1
DOIs
StatePublished - Oct 2004

Fingerprint

Acinar Cells
Submandibular Gland
Adrenergic Receptors
Prazosin
Binding Sites
Reverse Transcription
Polymerase Chain Reaction
Alkylating Agents
Cell Line
Messenger RNA
Membranes

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Submandibular gland acinar cells express multiple α1- adrenoceptor subtypes. / Bockman, Charles; Bruchas, Michael R.; Zeng, Wanyun; O'Connell, Kelly A.; Abel, Peter W.; Scofield, Margaret A.; Dowd, Frank J.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 311, No. 1, 10.2004, p. 364-372.

Research output: Contribution to journalArticle

Bockman, Charles ; Bruchas, Michael R. ; Zeng, Wanyun ; O'Connell, Kelly A. ; Abel, Peter W. ; Scofield, Margaret A. ; Dowd, Frank J. / Submandibular gland acinar cells express multiple α1- adrenoceptor subtypes. In: Journal of Pharmacology and Experimental Therapeutics. 2004 ; Vol. 311, No. 1. pp. 364-372.
@article{e12daac465cd4735b1d0867f833fadb9,
title = "Submandibular gland acinar cells express multiple α1- adrenoceptor subtypes",
abstract = "We evaluated an acinar cell line (SMG-C10) cloned from rat submandibular glands as a possible model for α1-adrenoceptor regulation of submandibular function. α1-Adrenoceptors are subdivided into three subtypes called α1A, α1B, and α1D, which can be distinguished from one another by their differential affinity values for subtype-selective α1- adrenoceptor antagonists. Thus, α1-adrenoceptor subtypes in SMG-C10 cells were characterized with reverse transcription-polymerase chain reaction (RT-PCR) and [3H]prazosin binding in side-by-side experiments with native submandibular glands. RT-PCR identified mRNAs for α1A-, α1B-, and α1D- adrenoceptors in SMG-C10 cells and submandibular glands. The inhibition of [3H]prazosin binding by 5-methylurapidil (α1A- selective) was biphasic and fit best to a two-site binding model with 40 ± 8{\%} high (KiH)- and 60 ± 10{\%} low (K iL)-affinity binding sites in SMG-C10 cells, and 76{\%} high- and 24{\%} low-affinity binding sites in submandibular glands. Respective KiH and KiL values for 5-methylurapidil were 1.9 ± 0.4 and 100 ± 30 nM in SMG-C10 cells and 3.2 ± 0.8 and 170 ± 20 nM in submandibular glands. BMY-7378 [8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 8-azaspiro[4.5]decane-7,9-dione dihydrochloride (α1D-selective) ] bound with low affinity in SMG-C10 cells and submandibular glands with K i values of 81 ± 20 and 110 ± 20 nM, respectively. Chloroethylclondine, an irreversible alkylating agent selective for α1B adrenoceptors, reduced the density of [3H] prazosin binding sites by 42 and 26{\%} in SMG-C10 and submandibular membranes, respectively. Thus, SMG-C10 cells and submandibular glands are similar in expressing receptor protein for α1A- and α1B- adrenoceptor subtypes, establishing SMG-C10 cells as a potential model for α1-adrenoceptor-mediated secretion.",
author = "Charles Bockman and Bruchas, {Michael R.} and Wanyun Zeng and O'Connell, {Kelly A.} and Abel, {Peter W.} and Scofield, {Margaret A.} and Dowd, {Frank J.}",
year = "2004",
month = "10",
doi = "10.1124/jpet.104.066399",
language = "English",
volume = "311",
pages = "364--372",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Submandibular gland acinar cells express multiple α1- adrenoceptor subtypes

AU - Bockman, Charles

AU - Bruchas, Michael R.

AU - Zeng, Wanyun

AU - O'Connell, Kelly A.

AU - Abel, Peter W.

AU - Scofield, Margaret A.

AU - Dowd, Frank J.

PY - 2004/10

Y1 - 2004/10

N2 - We evaluated an acinar cell line (SMG-C10) cloned from rat submandibular glands as a possible model for α1-adrenoceptor regulation of submandibular function. α1-Adrenoceptors are subdivided into three subtypes called α1A, α1B, and α1D, which can be distinguished from one another by their differential affinity values for subtype-selective α1- adrenoceptor antagonists. Thus, α1-adrenoceptor subtypes in SMG-C10 cells were characterized with reverse transcription-polymerase chain reaction (RT-PCR) and [3H]prazosin binding in side-by-side experiments with native submandibular glands. RT-PCR identified mRNAs for α1A-, α1B-, and α1D- adrenoceptors in SMG-C10 cells and submandibular glands. The inhibition of [3H]prazosin binding by 5-methylurapidil (α1A- selective) was biphasic and fit best to a two-site binding model with 40 ± 8% high (KiH)- and 60 ± 10% low (K iL)-affinity binding sites in SMG-C10 cells, and 76% high- and 24% low-affinity binding sites in submandibular glands. Respective KiH and KiL values for 5-methylurapidil were 1.9 ± 0.4 and 100 ± 30 nM in SMG-C10 cells and 3.2 ± 0.8 and 170 ± 20 nM in submandibular glands. BMY-7378 [8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 8-azaspiro[4.5]decane-7,9-dione dihydrochloride (α1D-selective) ] bound with low affinity in SMG-C10 cells and submandibular glands with K i values of 81 ± 20 and 110 ± 20 nM, respectively. Chloroethylclondine, an irreversible alkylating agent selective for α1B adrenoceptors, reduced the density of [3H] prazosin binding sites by 42 and 26% in SMG-C10 and submandibular membranes, respectively. Thus, SMG-C10 cells and submandibular glands are similar in expressing receptor protein for α1A- and α1B- adrenoceptor subtypes, establishing SMG-C10 cells as a potential model for α1-adrenoceptor-mediated secretion.

AB - We evaluated an acinar cell line (SMG-C10) cloned from rat submandibular glands as a possible model for α1-adrenoceptor regulation of submandibular function. α1-Adrenoceptors are subdivided into three subtypes called α1A, α1B, and α1D, which can be distinguished from one another by their differential affinity values for subtype-selective α1- adrenoceptor antagonists. Thus, α1-adrenoceptor subtypes in SMG-C10 cells were characterized with reverse transcription-polymerase chain reaction (RT-PCR) and [3H]prazosin binding in side-by-side experiments with native submandibular glands. RT-PCR identified mRNAs for α1A-, α1B-, and α1D- adrenoceptors in SMG-C10 cells and submandibular glands. The inhibition of [3H]prazosin binding by 5-methylurapidil (α1A- selective) was biphasic and fit best to a two-site binding model with 40 ± 8% high (KiH)- and 60 ± 10% low (K iL)-affinity binding sites in SMG-C10 cells, and 76% high- and 24% low-affinity binding sites in submandibular glands. Respective KiH and KiL values for 5-methylurapidil were 1.9 ± 0.4 and 100 ± 30 nM in SMG-C10 cells and 3.2 ± 0.8 and 170 ± 20 nM in submandibular glands. BMY-7378 [8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- 8-azaspiro[4.5]decane-7,9-dione dihydrochloride (α1D-selective) ] bound with low affinity in SMG-C10 cells and submandibular glands with K i values of 81 ± 20 and 110 ± 20 nM, respectively. Chloroethylclondine, an irreversible alkylating agent selective for α1B adrenoceptors, reduced the density of [3H] prazosin binding sites by 42 and 26% in SMG-C10 and submandibular membranes, respectively. Thus, SMG-C10 cells and submandibular glands are similar in expressing receptor protein for α1A- and α1B- adrenoceptor subtypes, establishing SMG-C10 cells as a potential model for α1-adrenoceptor-mediated secretion.

UR - http://www.scopus.com/inward/record.url?scp=4644248647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644248647&partnerID=8YFLogxK

U2 - 10.1124/jpet.104.066399

DO - 10.1124/jpet.104.066399

M3 - Article

C2 - 15265978

AN - SCOPUS:4644248647

VL - 311

SP - 364

EP - 372

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -